We are monitoring the impact of COVID-19 & Recession alarm on Latin America Biopharmaceuticals Market Get in touch with us for detailed analysis Know More
Share on

Latin America Biopharmaceuticals Market Research Report – Segmented By Product Type, By Therapeutic Type & By Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 585
Pages: 145

Latin America Biopharmaceuticals Market Size (2022 to 2027)

The Latin America Biopharmaceuticals Market is predicted to achieve USD 29.56 billion in 2022 and is estimated to grow at a CAGR of 9.67% to reach USD 46.89 billion by 2027.

Increased government initiatives such as the Growth Acceleration Program and the Greater Brazil Plan to increase domestic pharmaceutical production in Brazil and increased Foreign Direct Investment in the region are primarily accelerating the market growth for biopharmaceuticals in Latin America. However, when it comes to biological medications, particularly biosimilars, Latin America offers many potentials. Because Latin America has a high level of competence and development in biosimilars, local and multinational pharmaceutical companies are eager to enter the market to explore, create, and commercialize locally and internationally.

A greater emphasis on research and associated investments is assisting in meeting the high demand for biopharmaceuticals. In addition, biopharmaceutical products' capacity to treat previously untreatable conditions has resulted in the introduction of novel medications to the market. As a result of all factors, the market under consideration is predicted to expand throughout the forecast period.

Furthermore, the desire to avoid the side effects of small-molecule drugs and invasive surgical therapies is driving up the demand for biopharmaceuticals. As a result, Latin America is one of the largest pharmaceutical marketplaces in the world. The Latin American pharmaceutical market is expected to increase at 9% per year until 2028, and it is now more significant than the African and Middle Eastern markets combined. Brazil's pharmaceutical market is larger than the UK, Italy, Canada, and Spain combined, and it is predicted to surpass France to become the world's fifth-largest by 2024.

The key restraint confronting competitors in the Latin American biopharmaceuticals market are the high costs of R&D and the clinical trials required to prove product effectiveness and safety, as well as the necessity to keep final prices low. As a result, regional biologics firms aim to license their medicines to global players to expand their businesses.

This research report on the Latin America Biopharmaceuticals Market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Monoclonal Antibodies (mAb)       
  • Erythropoietin       
  • Biotech Vaccines 
  • Recombinant Human (RH) Insulin
  • Granulocyte colony-stimulating factor (G-CSF)       
  • Interferon               
  • Human growth hormones (HGH)  

By Therapeutic Type: 

  • Neurology
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiovascular
  • Other Therapeutic Areas

By Country: 

  • Brazil
  • Argentina
  • Chile
  • Mexico
  • Rest of Latin America

Regionally, Latin American accounted for a moderate share in the global market in 2020. But the scenario is expected to change in the coming years and is predicted to register a healthy growth rate between 2022 to 2027.

In Latin America, the Brazilian market is projected to showcase significant growth during the forecast period, followed by Mexico and Argentina.


A few of the prominent companies operating in the Latin America Biopharmaceuticals market profiled in this report are Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc. and Novartis AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Argentina    

                                6.5 Rest of Latin America             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 


                a) List of Tables                

                b) List of Figures                              

  1.  Latin America Biopharmaceuticals market By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  3. Latin America Monoclonal Antibodies (mAb) Market By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Erythropoietin Market By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Biotech Vaccines Market By Region, From 2022 - 2027 (USD Billion)
  6. Latin America Recombinant Human (RH) Insulin Market By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2022 - 2027 (USD Billion)
  8. Latin America Interferon Market By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Human growth hormones (HGH) Market By Region, From 2022 - 2027 (USD Billion)
  10. Latin America Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  11. Latin America Neurology Market By Region, From 2022 - 2027 (USD Billion)
  12. Latin America Infectious diseases Market By Region, From 2022 - 2027 (USD Billion)
  13. Latin America Diabetes Market By Region, From 2022 - 2027 (USD Billion)
  14. Latin America Oncology Market By Region, From 2022 - 2027 (USD Billion)
  15. Latin America Cardiovascular Market By Region, From 2022 - 2027 (USD Billion)
  16. Latin America Other Therapeutic Areas Market By Region, From 2022 - 2027 (USD Billion)
  17. Brazil Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  18. Brazil Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  19. Argentina Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  20. Argentina Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  21. Mexico Biopharmaceuticals market By Product Type, From 2022 - 2027 (USD Billion)
  22. Mexico Biopharmaceuticals market By Therapeutic Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample